tumor expansion trial
Scope
Date
~
-
Korean startups
Patty-cooking robotics startup Aniai completes seed funding
Aniai Inc., a foodservice robotics developer founded by a South Korean, said on Feb. 21 it has attracted $3 million via a seed funding round to boos...
Feb 21, 2023 (Gmt+09:00)
-
Food & Beverage
Kyochon sets sights on Western expansion with Canadian franchise deal
Kyochon F&B, the operator of South Korea's premier fried chicken brand Kyochon Chicken, said on Tuesday that it has secured a master franchise a...
Feb 21, 2023 (Gmt+09:00)
-
Batteries
S.Korea's EcoPro boosts raw material plant for cathode materials
South Korea's EcoPro Co., a leading cathode supplier for global battery makers, is expanding its plant for raw materials used in secondary battery c...
Feb 15, 2023 (Gmt+09:00)
-
Robotics
Hyundai Elevator's open API sees rapid expansion of participants
Hyundai Elevator Group announced on Tuesday that its open API (application programming interface), which was launched in March last year, has seen r...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem builds S.Korea's first plant for clinical trials
LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Aerospace & Defense
Low-cost carriers in S.Korea returning to profitability
South Korea's low-cost carriers (LCC) Jeju Air Co. and Jin Air in the fourth quarter last year each earned operating profit for the first time since...
Feb 08, 2023 (Gmt+09:00)
-
Chemical Industry
Toray Korea to boost PPS resin production with expansion plan
Toray Advanced Materials Korea (TAK) has announced plans to increase its annual production capacity of polyphenylene sulfide (PPS) resin by 5,000 to...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Airlines
South Korea's Jeju Air to open up Indonesian skies
Jeju Air Co. and Indonesia's largest airline corporation will work together to develop flight routes and discover new tourism business opportunities...
Jan 31, 2023 (Gmt+09:00)
-
Chief Executives
Samsung Biologics CEO focuses on global business
John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Kolmar Korea to establish new cosmetics production base in Sejong City
South Korea's cosmetic original design manufacturer Kolmar Korea said Wednesday that it would establish a cosmetics production base equipped with ar...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio's diagnostic products start to be used in clinical tests in Vietnam
South Korea's medical diagnostics company NGeneBio Co. said on Wednesday that it is expanding its business in the Southeast Asian precision diagnost...
Jan 19, 2023 (Gmt+09:00)
-
Banking & Finance
BC Card eyes Central Asian payment market entry this year
South Korea's financial services company BC Card said on Wednesday that it would seek to enter the Central Asian market this year on the back of its...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK bio families to present visions to global investors at SK Bio Night
SK Inc., the investment company of SK Group, said on Tuesday that it will hold a networking event called "SK Bio Night" in the US along with its bio...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GCCL develops Korea's first automatic clinical trial data sharing system
Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Kore...
Jan 10, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
LG Elec to increase partnerships for business expansion
LAS VEGAS -- LG Electronics Inc., the world’s top home appliance maker, is seeking more partnerships with global leading companies and increas...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Venture capital
Document tool company Business Canvas secures Series A2 round
Business Canvas, a South Korean SaaS (software as a service) startup that services the global document tool "Typed," announced on Tuesday that it ha...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
Latest News
- 1 Google to invest $100 mn in Gentle Monster in smart glasses push
- 2 Growth equity portfolio largely shielded from policy headwinds: Summit
- 3 Naver Financial seeks to acquire S. Korean real estate data platform Asil
- 4 KakaoBank shares surge on Thai virtual bank approval
- 5 Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma